Bloodpril and L-Arginine After a Heart Attack: The Trial Nobody Mentions
Of everything on this site, this is the finding we would most want a reader with heart disease to see. It concerns the ingredient class rather than the brand, and it appears on no page selling it.
A controlled trial of L-arginine supplementation in patients recovering from myocardial infarction was terminated early because more deaths occurred in the arginine group.
What the trial found
The study investigated whether L-arginine supplementation, added to standard post-infarction care, would improve vascular stiffness and ejection fraction in patients recovering from a heart attack. The hypothesis was reasonable: nitric oxide supports endothelial function, and endothelial function is impaired after infarction.
It did not work out that way. The trial was terminated early after more deaths occurred among participants receiving L-arginine than among those receiving placebo. The measured vascular endpoints showed no benefit either.
How to weigh it fairly
This deserves proportion rather than alarm, so here is the honest framing.
It is one trial, in a specific population — older patients recovering from a recent myocardial infarction, not healthy adults. The mechanism behind the signal has never been definitively established. Proposed explanations involve nitric oxide handling in already-damaged vasculature, where additional NO may behave differently from how it behaves in a healthy vessel.
It should not be generalised into “arginine is dangerous.” Millions of people take it without incident, and it occurs naturally in protein-rich food.
But it has never been overturned, and it has not been replicated in a way that resolves it either. In that situation, an unexplained mortality signal in exactly the population most likely to buy a cardiovascular supplement is not something to leave unmentioned.
Compare Bloodpril packages and discount pricing
The two-bottle package is a 60-day supply against a 60-day guarantee — the only option whose full cost stays inside your refund window.
See Bloodpril pricingAffiliate link. We may earn a commission at no additional cost to you. Verified 2026-08-22.
What we would do
If you have had a heart attack, or have established coronary artery disease, treat any arginine-containing supplement as a cardiologist conversation rather than a personal choice. Not a pharmacist, not a website, and not a decision made from a sales page.
Take the ingredient list to your next appointment. The conversation takes two minutes and your cardiologist can weigh a single trial finding against your specific situation in a way nobody writing a general-audience article can.
And if you have no cardiac history, this finding is not a reason to avoid the product. The reason to think twice about this particular product remains the dose.
The timeline we would delete
The official page publishes a five-stage results timeline — Day 7, Day 30, Day 60, Day 90 and Day 180 — each promising specific outcomes.
Day 30 says “morning readings begin trending more positively.” Day 60 says the “vascular stiffness and resistance that produced elevated readings has meaningfully decreased.” Day 90 promises “comprehensive cardiovascular transformation.”
There is no basis for any of it. No trial has been run on this product, and the doses that produced measurable blood pressure changes in the literature are ten to thirty times what this supplies.
One detail is worth noticing on its own. The Day 60 entry closes with: “Most users ordering the 2-bottle package reorder at this point.” That is not a statement about vascular biology. It is a reorder prompt, placed at exactly the moment the 60-day guarantee expires.
Independent background reading, none of it selling anything: the NHLBI DASH eating plan, CDC on high blood pressure and FTC health products compliance guidance. For the applied version of this on our own pages, see what the product actually is or the Bloodpril official website reference.
What we would do
Take the ingredient list to a pharmacist before ordering if you take anything cardiovascular, and to a cardiologist if you have had a heart attack. Buy a validated upper-arm monitor and record twice-daily readings for a fortnight before your first capsule so you have a baseline rather than an impression. Choose the two-bottle package, since 60 days of product against a 60-day guarantee is the only combination that keeps your whole spend inside the refund window. Diarise day 50 on the day you order.
Frequently asked
Ask your prescriber first. These amino acids act on the nitric oxide pathway and can add to the effect of antihypertensive treatment.
Not without medical advice. Nitrates donate nitric oxide and PDE5 inhibitors prolong its signal; adding a precursor creates three routes to the same vasodilation.
Yes. A randomised trial of L-arginine in post-infarction patients was halted early because more deaths occurred in the arginine group. Treat this as a cardiologist conversation.
No, never. Improved readings on medication mean the medication is working. Any dose change is a monitored conversation with your prescriber.
Disclaimer. This formula acts on the nitric oxide pathway — the same pathway as nitrate medicines such as nitroglycerin and isosorbide, and as PDE5 inhibitors such as sildenafil. Take the ingredient list to a pharmacist before ordering if you take any cardiovascular medication, and to a cardiologist if you have had a heart attack. Never stop or reduce prescribed blood pressure medication to take a supplement. These statements have not been evaluated by the Food and Drug Administration, and Bloodpril is not intended to diagnose, treat, cure or prevent any disease.
Affiliate disclosure. This page contains affiliate links. We may earn a commission if you purchase through them, at no additional cost to you. That does not change what we publish — see our full disclosure.